M Komulainen

Summary

Affiliation: University of Kuopio
Country: Finland

Publications

  1. ncbi Prevention of femoral and lumbar bone loss with hormone replacement therapy and vitamin D3 in early postmenopausal women: a population-based 5-year randomized trial
    M Komulainen
    Department of Obstetrics and Gynecology, Kuopio University Hospital, University of Kuopio, Finland
    J Clin Endocrinol Metab 84:546-52. 1999
  2. ncbi HRT and Vit D in prevention of non-vertebral fractures in postmenopausal women; a 5 year randomized trial
    M H Komulainen
    Department of Obstetrics and Gynecology, Kuopio University Hospital, Finland
    Maturitas 31:45-54. 1998
  3. ncbi HRT and Vit D in prevention of non-vertebral fractures in postmenopausal women; a 5 year randomized trial
    Marja H Komulainen
    Department of Obstetrics and Gynecology, Kuopio University Hospital, Kuopio, Finland
    Maturitas 61:85-94. 2008
  4. ncbi Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without vitamin D3: a prospective, controlled, randomized study
    A M Heikkinen
    Department of Obstetrics and Gynecology, University Hospital of Kuopio, Finland
    J Clin Endocrinol Metab 82:2476-82. 1997
  5. ncbi Identification of early postmenopausal women with no bone response to HRT: results of a five-year clinical trial
    M Komulainen
    Department of Obstetrics and Gynecology, Kuopio University Hospital, Finland
    Osteoporos Int 11:211-8. 2000
  6. ncbi The protective effect of hormone-replacement therapy on fracture risk is modulated by estrogen receptor alpha genotype in early postmenopausal women
    T Salmen
    Department of Biochemistry, University of Kuopio, Finland
    J Bone Miner Res 15:2479-86. 2000
  7. ncbi Postmenopausal hormone replacement therapy and autoantibodies against oxidized LDL
    A M Heikkinen
    Kuopio University Hospital, Finland
    Maturitas 29:155-61. 1998

Collaborators

Detail Information

Publications7

  1. ncbi Prevention of femoral and lumbar bone loss with hormone replacement therapy and vitamin D3 in early postmenopausal women: a population-based 5-year randomized trial
    M Komulainen
    Department of Obstetrics and Gynecology, Kuopio University Hospital, University of Kuopio, Finland
    J Clin Endocrinol Metab 84:546-52. 1999
    ..The data suggest that low dose vitamin D3 supplementation does not prevent bone loss in healthy, nonosteoporotic, early postmenopausal women, and it confers no benefit additional to that of HRT alone...
  2. ncbi HRT and Vit D in prevention of non-vertebral fractures in postmenopausal women; a 5 year randomized trial
    M H Komulainen
    Department of Obstetrics and Gynecology, Kuopio University Hospital, Finland
    Maturitas 31:45-54. 1998
    ..We investigated the incidence of new non-vertebral fractures during HRT or low-dose vitamin (Vit) D3 supplementation in a 5-year prospective trial...
  3. ncbi HRT and Vit D in prevention of non-vertebral fractures in postmenopausal women; a 5 year randomized trial
    Marja H Komulainen
    Department of Obstetrics and Gynecology, Kuopio University Hospital, Kuopio, Finland
    Maturitas 61:85-94. 2008
    ..CONCLUSIONS: This study is the first prospective trial confirming the beneficial effect of HRT on prevention of peripheral fractures in non-osteoporotic postmenopausal women. The effect of low-dose Vit D remains to be proved...
  4. ncbi Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without vitamin D3: a prospective, controlled, randomized study
    A M Heikkinen
    Department of Obstetrics and Gynecology, University Hospital of Kuopio, Finland
    J Clin Endocrinol Metab 82:2476-82. 1997
    ..Low dose vitamin D treatment, however, seems to have only marginal effects on bone metabolism in early postmenopausal healthy women...
  5. ncbi Identification of early postmenopausal women with no bone response to HRT: results of a five-year clinical trial
    M Komulainen
    Department of Obstetrics and Gynecology, Kuopio University Hospital, Finland
    Osteoporos Int 11:211-8. 2000
    ..Repeated serum FSH, estradiol and alkaline phosphatase measurements during the first months of long-term HRT may be helpful in identifying the women with no bone response to HRT...
  6. ncbi The protective effect of hormone-replacement therapy on fracture risk is modulated by estrogen receptor alpha genotype in early postmenopausal women
    T Salmen
    Department of Biochemistry, University of Kuopio, Finland
    J Bone Miner Res 15:2479-86. 2000
    ..The results suggest that the pp genotype is a relatively hormone-insensitive genotype, and it appears that women with the P allele may benefit more from the protective effect of HRT on fracture risk than women with the pp genotype...
  7. ncbi Postmenopausal hormone replacement therapy and autoantibodies against oxidized LDL
    A M Heikkinen
    Kuopio University Hospital, Finland
    Maturitas 29:155-61. 1998
    ..The antioxidant effect and inhibition of LDL oxidation may be one of the cardioprotective mechanisms of postmenopausal estrogen therapy...